Invesco Biotechnology & Genome ETF (PBE): ETF
ETF traded on ARCX under symbol PBE. Quoted in usd.
Invesco Biotechnology & Genome ETF
-0.17%$99.03
ARCX:PBEEquity
AUM $429.72M·YTD --·Yield --
ARCX:PBE$99.03-0.17%AUM $429.72MTop Holdings
49.3% of portfolio in top 10 holdings
Concentrated in Healthcare (100.0%)
Performance:
 | GILD Gilead Sciences Inc | +15.71% | 143.6K | |
 | BIIB Biogen Inc | +11.42% | 96.8K | |
 | RPRX Royalty Pharma PLC | +19.24% | 344.2K | |
 | REGN Regeneron Pharmaceuticals Inc | +22.42% | 25.6K | |
 | NTRA Natera Inc | -22.46% | 63.5K | |
 | AMGN Amgen Inc | +14.36% | 48.3K | |
 | VRTX Vertex Pharmaceuticals Inc | +8.91% | 38.6K | |
 | ILMN Illumina Inc | -22.08% | 95.0K | |
 | MRNA Moderna Inc | +35.60% | 73.4K | |
 | EXEL Exelixis Inc | +19.27% | 205.5K | |
 | VCEL Vericel Corp | +36.38% | 269.6K | |
 | QGEN QIAGEN NV | +10.25% | 267.0K | |
 | HALO Halozyme Therapeutics Inc | -5.55% | 106.6K | |
 | UTHR United Therapeutics Corp | +3.77% | 22.5K | |
 | LEGN Legend Biotech Corp | +25.00% | 547.1K | |
 | TGTX TG Therapeutics Inc | +14.63% | 210.3K | |
 | NBIX Neurocrine Biosciences Inc | +13.14% | 76.0K | |
 | NVAX Novavax Inc | -4.77% | 1.23M | |
 | SRPT Sarepta Therapeutics Inc | +2.95% | 615.9K | |
 | RGEN Repligen Corp | -0.78% | 64.1K | |
 | COLL Collegium Pharmaceutical Inc | +10.65% | 424.2K | |
 | INCY Incyte Corp | +6.14% | 89.8K | |
 | PTGX Protagonist Therapeutics Inc | -4.79% | 77.4K | |
 | PTCT PTC Therapeutics Inc | +2.73% | 158.6K | |
 | BMRN BioMarin Pharmaceutical Inc | -0.34% | 176.3K |
Institutional Holders
Sector Breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.00% |
Holdings Treemap
Country Allocation
| Country | Weight |
|---|---|
| United States | 100.00% |